• Necrostatin-1 at the Cell-Death Crossroads

  2026-09-23

  Necrostatin-1 offers a way to interrogate RIP1 kinase-dependent necroptosis, while recent nanospike research reveals a distinct, mechanically initiated route to autophagic cell death. For translational researchers, keeping these mechanisms separate—and testing where they intersect—can sharpen assay design and strengthen interpretation across tissue-injury and cancer models.

• Neuroligin 1 Proteolysis Maintains Social Memory

  2026-09-23

  Liu et al. identify activity-dependent proteolysis of Neuroligin 1 in the ventral hippocampus as a mechanism that sustains social memory after social interaction. Their experiments connect secretase processing, the NLG1 intracellular fragment, cofilin signaling, and dendritic spine maturation, offering a mechanistic framework for memory maintenance rather than memory formation alone.

• CTOP for μ-Opioid Receptor Research

  2026-09-22

  CTOP enables receptor-level confirmation of μ-opioid signaling in cellular, membrane, and pain-model workflows. Its competitive pharmacology is especially useful for separating μ-opioid receptor effects from downstream circuit mechanisms implicated in mechanical hypersensitivity and analgesic tolerance.

• Exosomal SNORD52 Activates JAK2/STAT6 in HCC

  2026-09-22

  The reference study identifies hepatoma cell-derived exosomal SNORD52 as an intercellular signal that promotes M2 macrophage polarization through JAK2/STAT6 pathway activation. Its findings connect noncoding RNA transfer with immune remodeling in hepatocellular carcinoma and provide a rationale for testing pathway-directed perturbations in follow-up cancer research.

• Intravesical p21 mRNA-LNP Therapy for Bladder Cancer

  2026-09-21

  The reference study developed chemically modified CDKN1A/p21 mRNA packaged in lipid nanoparticles for localized intravesical treatment of bladder cancer. In cell and orthotopic mouse models, this nonviral strategy restored nuclear p21, altered cell-cycle and DNA-damage signaling, and suppressed tumor growth while limiting systemic distribution.

• E. coli Uracil-DNA Glycosylase (UDG) Guide

  2026-09-21

  E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, removes uracil residues from single- and double-stranded DNA to support PCR product contamination elimination and uracil-focused DNA repair workflows. It is intended for research use with DNA, not RNA, oligonucleotides shorter than six bases, or diagnostic and medical applications.

• DZNep: 3-Deazaneplanocin A Hydrochloride

  2026-09-20

  3-Deazaneplanocin A hydrochloride, also called DZNep, is an epigenetic research compound that reduces EZH2-associated PRC2 activity and H3K27me3. Its reported applications include AML cell studies, NAFLD models, and chromatin-state research, but it should not be treated as a direct substitute for locus-specific chromatin restoration.

• HyperFluor 488 Goat Anti-Mouse IgG for NET Imaging

  2026-09-19

  Build sensitive immunofluorescence, flow cytometry, and western blot workflows around a fluorescently labeled secondary antibody designed to detect mouse IgG. The workflow below translates psoriasis NETosis findings into practical controls, staining choices, and troubleshooting decisions without overstating assay performance.

• Gap19 for Reproducible Cx43 Assays

  2026-09-18

  Learn how Gap19 (SKU B4919), a selective connexin 43 hemichannel blocker, can clarify Cx43-dependent effects in viability, ATP-release, neuroprotection, and inflammation assays. The article provides scenario-based dosing, handling, interpretation, and supplier-selection guidance grounded in product data and primary literature.

• Exogenous NADH Enhances Aminoglycoside Killing

  2026-09-18

  This 2024 Virulence study shows that exogenous NADH can reprogram Edwardsiella tarda metabolism, increase ATP availability, and strengthen the bactericidal activity of neomycin and related antibiotics. Its main contribution is to frame bacterial metabolic state as an experimentally adjustable determinant of antibiotic efficacy, while also identifying important limits for translation across strains and settings.

• DIDS and the Cell-Biological Origins of Metastasis

  2026-09-17

  DIDS offers a mechanistic bridge between chloride transport, cell-death recovery, ER stress, and prometastatic state formation—if researchers design around its pleiotropy.

• Lactate Workflows for Metabolic–Immune Research

  2026-09-17

  Lactate can serve as both a quantitative readout of glycolytic activity and a controlled metabolic signal in cell, hypoxia, mitochondrial, and tumor–immune experiments. This practical guide presents compartment-aware workflows, assay controls, and troubleshooting strategies informed by a recent colorectal cancer study linking the NAT1–ENO1–lactate axis to PD-L1 stability.

• Streptavidin-Cy3: Assay Design for Barrier Biology

  2026-09-16

  Streptavidin-Cy3 combines high-affinity biotin capture with bright Cy3 fluorescence for spatially complex assays. This guide shows how to adapt a streptavidin cy3 conjugate to dynamic, barrier-rich samples while controlling accessibility, background, spectral overlap, and interpretation.

• HyperScript First-Strand cDNA Synthesis Kit Guide

  2026-09-16

  Build more reliable gene-expression workflows for low-abundance transcripts, structured RNA, and long cDNA targets with the HyperScript First-Strand cDNA Synthesis Kit. This practical guide connects primer selection, reverse-transcription conditions, and troubleshooting to biomarker validation workflows such as FOXM1 analysis in female lung adenocarcinoma.

• TEAD, Ferroptosis, and HCC: Study Insights

  2026-09-15

  This study combined multi-database bioinformatics with cell-based validation to identify TEAD2 and TEAD4 as clinically relevant factors in hepatocellular carcinoma. Its most important mechanistic finding is that TEAD2 loss promotes iron accumulation and oxidative cell death, linking Hippo pathway transcriptional control with ferroptosis and HCC prognosis.

7904 records 1/527 page Next 12345 下5页 Last page